DEYMED Diagnostic s.r.o.

DEYMED Diagnostic s.r.o. specializes in psychophysiological biofeedback systems, including neurofeedback headboxes and recording caps designed for EEG-based monitoring. Their product line also covers magnetic neural stimulation devices, as well as accessories like disposable and reusable electrodes (such as 9mm tin disc electrodes and ear electrode pairs), body harnesses for electrode attachment, and secondary batteries for powering these systems. These devices are primarily used in clinical and research settings for brain activity monitoring and stimulation.

DEYMED Diagnostic s.r.o. is based in the United States, which means its devices fall under FDA regulatory oversight. The company’s products are classified as Class II devices under FDA regulations, indicating they pose moderate risk and require compliance with specific controls to ensure safety and effectiveness. The U.S. regulatory environment applies to these devices, including requirements like UDI labeling and registration.

DEYMED Diagnostic’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. The UDI system is used to track and identify medical devices throughout their distribution and helps ensure transparency in regulatory compliance. This listing is essential for traceability and adherence to FDA requirements for Class II devices.

DEYMED Diagnostic’s devices are classified as Class II under FDA regulations. This classification means they are considered to pose moderate risk and require special controls beyond general controls to ensure their safety and performance. The classification influences the regulatory pathway, including pre-market notifications (510(k)), labeling requirements, and post-market surveillance obligations. Class II status ensures these devices undergo rigorous evaluation to balance innovation with patient safety.